T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 4.07 USD -10.15% Market Closed
Market Cap: 119.3m USD
Have any thoughts about
TriSalus Life Sciences Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
TriSalus Life Sciences Inc

Current Assets 23.8m
Cash & Short-Term Investments 11.3m
Receivables 4.9m
Other Current Assets 7.6m
Non-Current Assets 3.7m
PP&E 3.2m
Other Non-Current Assets 424k
Current Liabilities 9.9m
Accounts Payable 1.4m
Accrued Liabilities 8.1m
Other Current Liabilities 363k
Non-Current Liabilities 38m
Long-Term Debt 21.7m
Other Non-Current Liabilities 16.3m

Balance Sheet
TriSalus Life Sciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1
0
0
12
Cash
1
0
0
0
Cash Equivalents
0
0
0
12
Total Receivables
0
0
0
4
Accounts Receivables
0
0
0
4
Other Receivables
0
0
0
0
Inventory
0
0
0
3
Other Current Assets
1
0
0
6
Total Current Assets
2
1
0
21
PP&E Net
0
0
0
3
PP&E Gross
0
0
0
3
Accumulated Depreciation
0
0
0
3
Intangible Assets
0
0
0
1
Other Long-Term Assets
250
250
20
0
Total Assets
252
N/A
251
-1%
20
-92%
26
+27%
Liabilities
Accounts Payable
0
1
1
3
Accrued Liabilities
0
0
0
11
Short-Term Debt
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
Other Current Liabilities
0
1
1
0
Total Current Liabilities
0
2
3
15
Long-Term Debt
0
0
1
0
Other Liabilities
23
16
10
37
Total Liabilities
24
N/A
17
-26%
14
-21%
52
+277%
Equity
Common Stock
224
250
20
0
Retained Earnings
1
17
13
248
Additional Paid In Capital
6
0
0
222
Total Equity
229
N/A
233
+2%
7
-97%
26
N/A
Total Liabilities & Equity
252
N/A
251
-1%
20
-92%
26
+27%
Shares Outstanding
Common Shares Outstanding
31
31
8
26
Preferred Shares Outstanding
0
0
0
4

See Also

Discover More